Autoimmunity to glutamate receptors in Rasmussen's encephalitis: A rare finding or the tip of an iceberg?

Neuroscientist

Volumn 4, Issue 5, 1998, Pages 373-379

  Gahring, Lorise C ^b   Rogers, Scott W ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HMBG   (United States)

Author keywords

Autoantibodies; Epilepsy; Glutamate; Neurobiology; Receptors

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE RECEPTOR; MONOCLONAL ANTIBODY;

AUTOIMMUNITY; DEGENERATIVE DISEASE; ENCEPHALITIS; EPILEPSY; HUMAN; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; REVIEW; SEIZURE;

EID: 0031664943     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849800400519     Document Type: Review

References (42)

1. Lange KW, Riederer P. Glutamatergic drugs in Parkinson's disease. Life Sci 1994;55:2067-2075.
2. Giacobini E. Nicotine acetylcholine receptors in human cortex: aging andxAlzheimer's disease. In: Lippiello PM, Collins AC, Gray AC, Robinson JH, editors. Biology of nicotine. New York: Raven Press; 1992. p. 183-215.
3. Koningsmark VW, Weiner LP. The olivopontocerebellar atrophies: A review. Medicine 1970;4:227-241.
4. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Nature 1973;180:871-872.
5. Olsen, RW, Avoli M. GABA and epileptogenesis. Epilepsia 1997; 38:399-407.
6. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;l:623-634.
7. Olney JW. Excitotoxic amino acids and neuropsychiatrie disorders. Ann Rev Pharmacol Toxicol 1990;30:47-71.
8. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Ann Rev Pharmacol Toxicol 1989;29:365-402.
9. Hollmann M, Heinemann S. Cloned glutamate receptors. Ann Rev Neurosci 1994;17:31-108.
10. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-652.
11. Twyman RE, Gahring LC, Speiss J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995;14:755-762.
12. Gahring LC, Twyman RE, Greenlee JE, Rogers SW. Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Mol Med 1995; 1:245-253.
13. Gahring LC, Twyman RE, Rogers SW. Autoantibodies to glutamate receptor subunit GluR2 in non-familial olivopontocerebellar degeneration. Neurology 1997;48:494-500.
14. Rasmussen, TB. Chronic encephalitis and seizure: Historical introduction. In: Andermann F, editor. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Stoneham (MA): Butterworth-Heinemann; 1991. p. 1-4.
15. Ogoni H, Andermann F, Rasmussen TB. The natural history of chronic encephalitis and epilepsy; a study of the MRI series of forty-eight cases. In: Andermann F, editor. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Stoneham (MA): Butterworth-Heinemann; 1991. p. 7-35.
16. Vining EP, Freeman JM, Pillas DJ, et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomythe Johns Hopkins experience: 1968 to 1996. Pediatrics 1997; 100: 163-171.
17. DeBates MH, Vincent, A. Myasthenia gravis. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, editors. The molecular pathology of autoimmune diseases. Reading (UK): Harwood Academic Publishers; 1993. p. 1-14.
18. Kami A, Zisman E, Katz-Levy Y, et al. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology 1997;19:1638-1642.
19. Engel AG, Hutchinson DO, Nakano S, et al. Myasthenie syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptor. Ann NY Acad Sci 1993;681:496-508.
20. Andermann E, Oguni H, Guttman RD, et al. Genetic aspects of chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Stoneham (MA): Butterworth-Heinemann; 1991. p. 167-175.
21. Power C, Poland SD, Blume WT, Girvin JP, Rice GPA. Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990;336: 1282-1284.
22. Jay V, Decker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995;45:I08-117.
23. Asher DM, Gajdusek DC. Virology studies in chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy: Rasmussen's syndrome. Stoneham (MA): Butterworth-Heinemann; 1991. p. 147-158.
24. McLachlan RM, Levin S, Blume, WT. Treatment of Rasmussen's syndrome with ganciclovir. Neurology 1996;47:925-928.
25. Dabbagh O, Gascon G, Crowell J, Bamoggadam F. Intraventricular interferon-a stops seizures in Rasmussen's encephalitis: A case report. Epilepsia 1997;38:1045-1049.
26. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JA. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996; 46:242-246.
27. Hollmann M, Maron C, Heinemann S. W-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluRl. Neuron 1994;13:1331-1343.
28. Stem-Bach Y, Bettler B, Hartely M, Sheppard PO, O'Hara PJ, Heinemann SF. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acidbinding proteins. Neuron 1994; 13:1345-57.
29. Carlson NG, Gahring LC, Twyman RE, Rogers SW. Identification of amino acids in the glutamate receptor subunit, GluR3, important for antibody-binding and receptor activation. J Biol Chem 1997;272:11295-11301.
30. Neuwelt EA, Frankel EP. The challenge of the blood-brain barrier. In Neuwelt EA, editor. Implications of the blood-brain barrier and its manipulation. Vol. 1. New York: Plenum; 1989. p. 1-26.
31. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. Glia 1988;1:301-307.
32. Wekerle H. Lymphocyte traffic to the brain. In: Pardridge WH, editor. The blood-brain barrier cellular and molecular biology. New York: Raven Press; 1993. p. 67-85.
33. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990;8:579-621.
34. Friedman A, Kaufer D, Semer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. NatMed 1996;2:1382-1385.
35. Rogers SW, Hughes T, Hollmann M, Gasic G, Deneris E, Heinemann S. The characterization and localization of the glutamate receptor subunit, GluRl, in the rat brain. J Neurosci 1991; 11:2713-2724.
36. Oztas B, Camurcu S, Kaya M. Influence of sex on the blood brain barrier permeability during bicuculline induced seizures. Int J Neurosci 1992;65:131-139.
37. Candore G, DiLorenzo G, Mansueto P, et al. Prevalence of organspecific and non organ-specific autoantibodies in healthy centenarians. Mech Ageing Dev 1997;94:183-190.
38. Cunnigham M. Bacterial Antigen Mimicry. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, editors. The molecular pathology of autoimmune diseases. Reading (UK): Harwood Academic Publishers; 1993. p. 245-256.
39. Ehrenstein M, Isenberg D. Autoimmunity associated with infection: Leprosy, acute rheumatic fever, and Lyme disease. Curr Opin Immunol 1991;3:930-932.
40. Gahring LC, Carlson NG, Rogers SW. Antibodies prepared to neuronal glutamate receptor subunit 3 bind IFNa-Receptors: Implications in an autoimmune disease. Autoimmunity 1998 (in press).
41. Mäkelä O, Karjalainen K. Inherited immunoglobulin idiotypes of the mouse. Immunol Rev 1977;34:119-138.
42. Uccelli LY, Laxer KD, Jeong MC, et al. Local-clonal expansion in infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 1997;158:1428-1437.